# Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation

> **NCT03791736** · NA · TERMINATED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 4 (actual)

## Conditions studied

- Breast Cancer
- Lymphocele

## Interventions

- **PROCEDURE:** Injection of sandostatine

## Key facts

- **NCT ID:** NCT03791736
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07-06
- **Primary completion:** 2018-07-06
- **Final completion:** 2018-07-06
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The surgical technique is no longer used
- **Last updated:** 2022-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03791736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03791736, "Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03791736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*